P12.25.B A GLOBAL PHASE 3, OPEN-LABEL, RANDOMIZED-CONTROLLED STUDY FOR NEWLY-DIAGNOSED, MGMT UNMETHYLATED GLIOBLASTOMA, COMPARING NIRAPARIB VS STANDARD OF CARE TEMOZOLOMIDE TREATMENT.
Publication
, Conference
Sanai, N; Mehta, S; Tien, A; Tovmasyan, A; Harmon, J; Kennedy, WR; Aziez, A; Chalmers, A; Khasraw, M; Lim Fat, M; Minniti, G; Sepulveda, JM ...
Published in: Neuro-Oncology
October 3, 2025
Duke Scholars
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
October 3, 2025
Volume
27
Issue
Supplement_3
Start / End Page
iii121 / iii121
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Sanai, N., Mehta, S., Tien, A., Tovmasyan, A., Harmon, J., Kennedy, W. R., … Umemura, Y. (2025). P12.25.B A GLOBAL PHASE 3, OPEN-LABEL, RANDOMIZED-CONTROLLED STUDY FOR NEWLY-DIAGNOSED, MGMT UNMETHYLATED GLIOBLASTOMA, COMPARING NIRAPARIB VS STANDARD OF CARE TEMOZOLOMIDE TREATMENT. In Neuro-Oncology (Vol. 27, pp. iii121–iii121). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noaf193.404
Sanai, N., S. Mehta, A. Tien, A. Tovmasyan, J. Harmon, W. R. Kennedy, A. Aziez, et al. “P12.25.B A GLOBAL PHASE 3, OPEN-LABEL, RANDOMIZED-CONTROLLED STUDY FOR NEWLY-DIAGNOSED, MGMT UNMETHYLATED GLIOBLASTOMA, COMPARING NIRAPARIB VS STANDARD OF CARE TEMOZOLOMIDE TREATMENT.” In Neuro-Oncology, 27:iii121–iii121. Oxford University Press (OUP), 2025. https://doi.org/10.1093/neuonc/noaf193.404.
Sanai N, Mehta S, Tien A, Tovmasyan A, Harmon J, Kennedy WR, et al. P12.25.B A GLOBAL PHASE 3, OPEN-LABEL, RANDOMIZED-CONTROLLED STUDY FOR NEWLY-DIAGNOSED, MGMT UNMETHYLATED GLIOBLASTOMA, COMPARING NIRAPARIB VS STANDARD OF CARE TEMOZOLOMIDE TREATMENT. In: Neuro-Oncology. Oxford University Press (OUP); 2025. p. iii121–iii121.
Sanai, N., et al. “P12.25.B A GLOBAL PHASE 3, OPEN-LABEL, RANDOMIZED-CONTROLLED STUDY FOR NEWLY-DIAGNOSED, MGMT UNMETHYLATED GLIOBLASTOMA, COMPARING NIRAPARIB VS STANDARD OF CARE TEMOZOLOMIDE TREATMENT.” Neuro-Oncology, vol. 27, no. Supplement_3, Oxford University Press (OUP), 2025, pp. iii121–iii121. Crossref, doi:10.1093/neuonc/noaf193.404.
Sanai N, Mehta S, Tien A, Tovmasyan A, Harmon J, Kennedy WR, Aziez A, Chalmers A, Khasraw M, Lim Fat M, Minniti G, Sepulveda JM, Touat M, Umemura Y. P12.25.B A GLOBAL PHASE 3, OPEN-LABEL, RANDOMIZED-CONTROLLED STUDY FOR NEWLY-DIAGNOSED, MGMT UNMETHYLATED GLIOBLASTOMA, COMPARING NIRAPARIB VS STANDARD OF CARE TEMOZOLOMIDE TREATMENT. Neuro-Oncology. Oxford University Press (OUP); 2025. p. iii121–iii121.
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
October 3, 2025
Volume
27
Issue
Supplement_3
Start / End Page
iii121 / iii121
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis